Advertisement
UK markets closed
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • CRUDE OIL

    82.52
    -0.29 (-0.35%)
     
  • GOLD FUTURES

    2,339.80
    +1.40 (+0.06%)
     
  • DOW

    37,988.29
    -472.63 (-1.23%)
     
  • Bitcoin GBP

    51,272.24
    -453.19 (-0.88%)
     
  • CMC Crypto 200

    1,386.17
    +3.60 (+0.26%)
     
  • NASDAQ Composite

    15,511.68
    -201.07 (-1.28%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

A Look at Novartis’s Innovative Medicines Business

A Look at Novartis’s Innovative Medicines Business

Novartis’s (NVS) Innovative Medicines business, which includes prescription pharmaceutical and oncology products, contributed over 66% of Novartis’s total revenue in Q1 2018. Its revenue grew 12% YoY (year-over-year) to $8.4 billion.